Cancer Breakthrough Fund backs Halifax's Sound Blade in histotripsy Series A
What's the deal? The Cancer Breakthrough Fund has invested in Sound Blade Medical, a Halifax-based company developing handheld histotripsy technology to treat cancer non-invasively. The deal closes Sound Blade's 2025 Series A, co-led by Amzak HealthDealroom has a profile for this one. Try Dealroom → and Lumira VenturesDealroom has a profile for this one. Try Dealroom →.
What's the endgame? Sound Blade is building a handheld device that uses histotripsy — a non-thermal, focused ultrasound technology — to mechanically destroy tumors and diseased tissue with high precision and no incisions. The aim is to reduce reliance on invasive surgery or radiation. The system is currently limited to investigational use and is not available for sale.
Who's backing it? The Cancer Breakthrough Fund is an oncology-focused fund managed by Lumira Ventures and launched with the Terry Fox Foundation. Its backers include the Canadian Cancer SocietyDealroom has a profile for this one. Try Dealroom → and a base of institutional investors, impact funds, foundations, and family offices.
Why now? The investment is the fund's second since its initial closing in May 2026. It combines venture capital with the clinical and scientific networks of two of Canada's leading philanthropic entities.
Sound Blade plans to use the support to accelerate development and move its platform into patient trials. "With this support and access to the fund's deep network of cancer researchers, clinical leaders, and strategic investors, we look forward to accelerating the development and introduction of our handheld histotripsy platform into patient trials," said Neil Barman, chief executive officer of Sound Blade.
The signal: Suman Rao, principal at Lumira Ventures, called histotripsy "a fundamentally new approach to tumor destruction and cancer immunotherapy." The backing points to growing investor appetite for non-invasive oncology tools and signals confidence in Canada's medtech ecosystem.
Read more: finanznachrichten.de
Image credit: Generated with Gemini
